Stockscreener 앱 받기
6.67
5.66%
-0.40
시간 외 거래:
6.59
-0.08
-1.20%
Novavax Inc 주식(NVAX)의 최신 뉴스
Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch
Novavax told by FDA to conduct additional study for COVID vaccinereport - Seeking Alpha
US FDA asks Novavax to complete new clinical trial for delayed COVID-19 shot, WSJ reports - Reuters
Novavax Asked by FDA to Run Additional Trial on COVID-19 Vaccine - marketscreener.com
Press Release Distribution & PR Platform - ACCESS Newswire
Novavax Falls on Report That FDA Wants New Covid Vaccine Trial - Bloomberg.com
FDA Requests New Novavax (NVAX) Covid-19 Vaccine Trial, Testing Company's Resources | NVAX Stock News - GuruFocus
Exclusive | FDA Asks Vaccine Maker to Complete New Clinical Trial for Delayed Covid-19 Shot - WSJ
Novavax COVID Vaccine Moves Closer to Full FDA Approval - yoursun.com
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
An Approvable Protein-Based COVID-19 Vaccine - Vax-Before-Travel
Novavax up 20% on ‘approvable’ COVID-19 vaccine development - The Pharma Letter
As FDA delays Novavax' COVID vaccine approval, patients fight back - Reuters
Novavax Jumps After FDA Asks for More Data on Its Covid Vaccine - MSN
As FDA delays Novavax’ COVID vaccine approval, patients fight back - Bilyonaryo Business News
Novavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains? - Yahoo Finance
Novavax (NVAX) Rises Amid FDA Data Request for COVID-19 Vaccine - GuruFocus
Novavax Says Its COVID Shot Is on Track for Full FDA Approval After Delay - MSN
Postmarketing Surprise Is Latest Plot Twist For Novavax’s COVID-19 Vaccine BLA - insights.citeline.com
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Novavax: New COVID-19 Vaccine on Track for FDA Approval - Inc.com
Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps - Benzinga
Novavax Highlights Technology Platform and Matrix-M® Adjuvant Potential at World Vaccine Congress - Novavax
Novavax Shares Surge 17% as FDA Requests Postmarketing Data for COVID-19 Vaccine - Yahoo Finance
Novavax shares soar after FDA request raises hope for COVID vaccine approval - Reuters
Sector Update: Health Care - marketscreener.com
Vaccine Makers Fall After RFK Jr. Says Some Shots Don’t Work - MSN
FDA asks Novavax for post-approval data on COVID vaccine, shares soar - marketscreener.com
Novavax's stock surges on 'good news' from Food and Drug Administration - The Business Journals
Novavax shares rise as FDA signals path to COVID vaccine approval - Proactive Investors
Vertiv earnings beat, DOJ & Disney–fuboTV deal, Novavax COVID shot - Yahoo Finance
Novavax says its COVID-19 shot is on track for full FDA approval after delay - MSN
Novavax (NVAX) Stock Soars After FDA Seeks More Data on COVID Vaccine - GuruFocus
FDA asks Novavax for post-approval data on COVID vaccine, raising hopes for green light - marketscreener.com
Novavax up on FDA's request for additional data for COVID-19 shot - MSN
Novavax Signals Chances Of FDA Approval For Its COVID-19 Vaccine: But Retail Sentiment Wavers By Stocktwits - Investing.com India
Novavax up on FDA's request for additional COVID-19 shot data (NVAX:NASDAQ) - Seeking Alpha
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - MSN
Amphenol Posts Better-Than-Expected Results, Joins SAP, Tesla, Pegasystems And Other Big Stocks Moving Higher On Wednesday - Benzinga
Novavax (NVAX) Sees Stock Surge Following FDA Communication on Nuvaxovid | NVAX Stock News - GuruFocus
Novavax Signals Chances Of FDA Approval For Its COVID-19 Vaccine: But Retail Sentiment Wavers - MSN
FDA asks Novavax for commitment on post-approval studies for COVID vaccine - 1470 & 100.3 WMBD
Novavax Says COVID Vaccine Application 'Approvable' - marketscreener.com
Novavax (NVAX) Awaits FDA Approval Following Additional Data Request | NVAX Stock News - GuruFocus
Novavax stock jumps on positive FDA discussions By Investing.com - Investing.com Canada
Novavax’s Biologics License Application Nears Approval - TipRanks
Novavax reveals FDA request for additional data By Investing.com - Investing.com India
0.24%
36.06%
자본화:
|
볼륨(24시간):